These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26418829)

  • 21. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
    Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
    Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.
    Beloqui A; Coco R; Memvanga PB; Ucakar B; des Rieux A; Préat V
    Int J Pharm; 2014 Oct; 473(1-2):203-12. PubMed ID: 25014369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral bomb effect nanotherapeutics alleviate ulcerative colitis through coordinated anti-inflammatory and pro-resolving strategies.
    Yang M; Zhu Y; Wei X; Feng J; He Y; Jiang J; Zhou Q; Zhang M; Zhang G; Ma W
    Biomater Sci; 2024 Oct; 12(20):5386-5403. PubMed ID: 39264298
    [No Abstract]   [Full Text] [Related]  

  • 25. Biophysical properties of chitosan/siRNA polyplexes: profiling the polymer/siRNA interactions and bioactivity.
    Holzerny P; Ajdini B; Heusermann W; Bruno K; Schuleit M; Meinel L; Keller M
    J Control Release; 2012 Jan; 157(2):297-304. PubMed ID: 21884740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
    Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
    Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo.
    Frede A; Neuhaus B; Klopfleisch R; Walker C; Buer J; Müller W; Epple M; Westendorf AM
    J Control Release; 2016 Jan; 222():86-96. PubMed ID: 26699423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI-assessed therapeutic effects of locally administered PLGA nanoparticles loaded with anti-inflammatory siRNA in a murine arthritis model.
    te Boekhorst BC; Jensen LB; Colombo S; Varkouhi AK; Schiffelers RM; Lammers T; Storm G; Nielsen HM; Strijkers GJ; Foged C; Nicolay K
    J Control Release; 2012 Aug; 161(3):772-80. PubMed ID: 22580113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urocanic acid-modified chitosan nanoparticles can confer anti-inflammatory effect by delivering CD98 siRNA to macrophages.
    Xiao B; Ma P; Viennois E; Merlin D
    Colloids Surf B Biointerfaces; 2016 Jul; 143():186-193. PubMed ID: 27011348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
    Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
    Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency.
    Ragelle H; Riva R; Vandermeulen G; Naeye B; Pourcelle V; Le Duff CS; D'Haese C; Nysten B; Braeckmans K; De Smedt SC; Jérôme C; Préat V
    J Control Release; 2014 Feb; 176():54-63. PubMed ID: 24389132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation.
    Yadav S; Gandham SK; Panicucci R; Amiji MM
    Nanomedicine; 2016 May; 12(4):987-1002. PubMed ID: 26767514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liquid Crystalline Nanodispersions Functionalized with Cell-Penetrating Peptides for Topical Delivery of Short-Interfering RNAs: A Proposal for Silencing a Pro-Inflammatory Cytokine in Cutaneous Diseases.
    Petrilli R; Eloy JO; Praça FS; Del Ciampo JO; Fantini MA; Fonseca MJ; Bentley MV
    J Biomed Nanotechnol; 2016 May; 12(5):1063-75. PubMed ID: 27305826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of Hepatic Inflammation via Systemic siRNA Delivery by Membrane-Disruptive and Endosomolytic Helical Polypeptide Hybrid Nanoparticles.
    He H; Zheng N; Song Z; Kim KH; Yao C; Zhang R; Zhang C; Huang Y; Uckun FM; Cheng J; Zhang Y; Yin L
    ACS Nano; 2016 Feb; 10(2):1859-70. PubMed ID: 26811880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics.
    Zhou X; Liu Y; Wang X; Li X; Xiao B
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110880. PubMed ID: 32098717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient intracellular delivery and multiple-target gene silencing triggered by tripodal RNA based nanoparticles: a promising approach in liver-specific RNAi delivery.
    Sajeesh S; Lee TY; Kim JK; Son DS; Hong SW; Kim S; Yun WS; Kim S; Chang C; Li C; Lee DK
    J Control Release; 2014 Dec; 196():28-36. PubMed ID: 25251899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model.
    Howard KA; Paludan SR; Behlke MA; Besenbacher F; Deleuran B; Kjems J
    Mol Ther; 2009 Jan; 17(1):162-8. PubMed ID: 18827803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-delivery of siRNA and hypericin into cancer cells by hyaluronic acid modified PLGA-PEI nanoparticles.
    Li Y; Zhang J; Wang B; Shen Y; Ouahab A
    Drug Dev Ind Pharm; 2016; 42(5):737-46. PubMed ID: 26472259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nebulised siRNA encapsulated crosslinked chitosan nanoparticles for pulmonary delivery.
    Sharma K; Somavarapu S; Colombani A; Govind N; Taylor KM
    Int J Pharm; 2013 Oct; 455(1-2):241-7. PubMed ID: 23876499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.